Tert-Butylamine

Tert-Butylamine

SCHEMBL9015792

CC(C)(C)N.CO

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACEIDH1

The experimentally established mechanism targets of Tert-Butylamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108546269-A The method that clavulanic acid tert-butylamine salt is recycled from crystalline mother solution 国药集团威奇达药业有限公司 2018-09-18 CN claimed
WO-2024005240-A1 INSULIN RECEPTOR-BINDING APTAMER DIMER AND USE THEREOF 포항공과대학교 산학협력단 2024-01-04 WO disclosed
CN-111808152-B Deacylation method of sucralose-6-acetate 山东新和成精化科技有限公司 2021-10-08 CN disclosed
CN-111808152-A Deacylation method of sucralose-6-acetate 山东新和成精化科技有限公司 2020-10-23 CN disclosed
CN-108546269-A The method that clavulanic acid tert-butylamine salt is recycled from crystalline mother solution 国药集团威奇达药业有限公司 2018-09-18 CN disclosed
CN-103333170-B Benzimidazoles compound and application thereof 清华大学 2016-08-10 CN disclosed
EP-3044334-A1 PDGF AND VEGF APTAMERS HAVING IMPROVED STABILITY AND THEIR USE IN TREATING PDGF AND VEGF MEDIATED DISEASES AND DISORDERS Somalogic, Inc. (US) 2016-07-20 EP disclosed
WO-2015035305-A1 PDGF AND VEGF APTAMERS HAVING IMPROVED STABILITY AND THEIR USE IN TREATING PDGF AND VEGF MEDIATED DISEASES AND DISORDERS SOMALOGIC, INC. (US) 2015-03-12 WO disclosed
US-5519126-A COMBATTING DISEASES BY BIOCHEMICL INTERVENTION AT THE RNA AND DNA LEVEL UNIVERSITY OF VIRGINIA ALUMNI PATENTS FOUNDATION (US) 1996-05-21 US disclosed
EP-0406309-A4 OLIGONUCLEOTIDE N-ALKYLPHOSPHORAMIDATES 1992-08-19 EP disclosed
EP-0406309-A1 OLIGONUCLEOTIDE N-ALKYLPHOSPHORAMIDATES THE UNIVERSITY OF VIRGINIA ALUMNI PATENTS FOUNDATION (US) 1991-01-09 EP disclosed
US-4973679-A Process for oligonucleo tide synthesis using phosphormidite intermediates UNIVERSITY PATENTS, INC. (US) 1990-11-27 US disclosed
WO-1989009221-A1 OLIGONUCLEOTIDE N-ALKYLPHOSPHORAMIDATES UNIVERSITY OF VIRGINIA ALUMNI PATENTS FOUNDATION (US) 1989-10-05 WO disclosed
US-4668777-A POLYNUCLEOTIDE INTERMEDIATES UNIVERSITY PATENTS, INC. (US) 1987-05-26 US disclosed
EP-0061746-B1 PHOSPHORAMIDITE COMPOUNDS AND THEIR USE IN PRODUCING OLIGONUCLEOTIDES UNIVERSITY PATENTS, INC. (US) 1985-03-20 EP disclosed
US-4500707-A Nucleosides useful in the preparation of polynucleotides UNIVERSITY PATENTS, INC. (US) 1985-02-19 US disclosed
EP-0061746-A1 Phosphoramidite compounds and their use in producing oligonucleotides UNIVERSITY PATENTS, INC. (US) 1982-10-06 EP disclosed
US-3981828-A ISOCYANATE TRIMERIZATION CATALYSTS BASF WYANDOTTE CORPORATION (US) 1976-09-21 US disclosed